UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Exclusive] MSD Korea playing tricks to reduce daycare cost
Korea Biomedical Review ran an exclusive story on an executive at MSD Korea...
by Kim Yun-mi
|
2019-05-09 11:20
라인
T&R Biofab, CiSTEM to co-develop rare disease treatments
T&R Biofab and CiSTEM have signed a technology transfer contract to develop...
by Lee Han-soo
|
2019-05-09 11:17
라인
‘GC Wellbeing’s placenta injection has liver regenerative effects’
GC Wellbeing, a subsidiary of GC, has released the results of a study regar...
by Lee Han-soo
|
2019-05-08 17:07
라인
Celgene’s myelodysplastic syndrome treatment gets more insurance benefits
The Ministry of Health and Welfare has granted additional reimbursement to ...
by Lee Han-soo
|
2019-05-07 17:36
라인
GC Cell to start developing CAR-T treatment for pancreatic cancer
GC Cell has concluded a material transfer agreement with Mogam Institute fo...
by Lee Han-soo
|
2019-05-07 16:10
라인
FDA OKs Gemvax & Kael's Alzheimer treatment for P2 trials
Gemvax & Kael has obtained U.S. Food and Drug Administration's investig...
by Lee Han-soo
|
2019-05-07 16:09
라인
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave
MSD Korea recently revised a policy to allow employees on child care leave ...
by Jeong Sae-im
|
2019-05-07 12:08
라인
Dong-A ST posts robust Q1 profit
Dong-A ST said Friday that it recorded sales of 142.6 billion won ($121.8 m...
by Lee Han-soo
|
2019-05-03 16:49
라인
Leading hepatitis C drug wins FDA nod for adolescents
AbbVie’s hepatitis C treatment Mavyret (glecaprevir/pibrentasvir), which wo...
by Kim Yun-mi
|
2019-05-03 15:51
라인
GC surpasses 200-million mark in flu vaccine production
GC has become the first local company to manufacture more than 200 million ...
by Lee Han-soo
|
2019-05-03 14:39
라인
Hanmi's short bowel syndrome treatment becomes orphan drug in US
The U.S. Food and Drug Administration has granted an orphan drug designatio...
by Lee Han-soo
|
2019-05-03 11:42
라인
Ministry OKs Lilly Korea’s metastatic breast cancer treatment
Lilly Korea has received sales approval from the Ministry of Food and Drug ...
by Lee Han-soo
|
2019-05-02 18:11
라인
GC marks sluggish sales in Q1
GC said Tuesday that sales by the company and its subsidiaries in the first...
by Lee Han-soo
|
2019-05-02 14:30
라인
Daewoong logs ₩238.1 billion sales in Q1
Daewoong Pharmaceutical recorded 238.1 billion won ($247.8 million) in sale...
by Lee Han-soo
|
2019-05-02 14:09
라인
‘MSD Korea’s monitoring program might be privacy breach’
MSD Korea’s “Self-Assurance” program, recording conversations of doctors at...
by Kim Yun-mi
|
2019-05-02 11:00
라인
Hanmi posts ₩274 billion in Q1 sales
Hanmi Pharmaceutical said Tuesday that it recorded sales of 274.6 billion w...
by Lee Han-soo
|
2019-05-02 10:59
라인
HanAll unveils P2 trial results at ARVO 2019
HanAll Biopharma has presented the phase 2 clinical trial for HL036, a dry ...
by Lee Han-soo
|
2019-04-30 16:31
라인
Drugmakers brace for vaccine shortage amid surging hepatitis A cases
Pharmaceutical companies are closely monitoring the supply of hepatitis A v...
by Kim Yun-mi
|
2019-04-30 13:13
라인
Daewoong gets positive reviews of its BTX in EU
Daewoong Pharmaceutical said Friday that the European Medicines Agency'...
by Lee Han-soo
|
2019-04-29 16:13
라인
Yuyu releases research results for dry eye treatment in Canada
Yuyu Pharmaceutical has presented the results of a study for YDE, its pepti...
by Lee Han-soo
|
2019-04-29 14:33
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top